Uterine angiomatosis as an unexpected cause of refractory pelvic pain and heavy menstrual bleeding: a case report and literature review Authors: Zubaydah Abdi, Sadia Zare, Ruth Grundy, Alexander Polson, Salwa Idle Published: 2026 ABSTRACT AbstractAngiomatosis is a rare benign vascular lesion characterised by diffuse, haphazard proliferation of blood vessels, most commonly within adipose and fibrous tissue. This report describes the case of a patient in her early 30s who presented with refractory menorrhagia and pelvic pain. Following total laparoscopic hysterectomy with bilateral salpingectomy, histopathological examination identified angiomatosis of the uterine corpus and cervix. This finding is exceptionally rare, with only five cases reported in the literature. Conventional investigations, including ultrasonography and hysteroscopy, may be inadequate, with definitive diagnosis often established only on postoperative histopathological analysis. Medical management appears largely ineffective in symptom control, with most reported cases resulting in hysterectomy. Given the limited number of reported cases, the natural progression of this condition is largely unknown, and postoperative surveillance may be warranted.Keywords: Case report, Uterine angiomatosis, Menorrhagia, Pelvic pain Introduction Angiomatosis is defined as diffuse benign vascular lesions involving the proliferation of blood vessels in skin, deep soft tissue and bone. Angiomatosis of the uterus is rare, with only five reported cases. This report outlines the case of a female patient in her 30s with dysmenorrhoea and menorrhagia diagnosed with angiomatosis of the uterine corpus and cervix following histopathological analysis. This case provides a further differential for abnormal uterine bleeding that clinicians should be aware of. Case Presentation Clinical Presentation A nulliparous woman in her early 30s presented with a history of chronic cyclical pelvic pain and heavy menstrual bleeding that was managed with depot medroxyprogesterone acetate injections for more than 10 years. Of late, her symptoms had not been well controlled and she wished to consider surgical management. Her past gynaecological history was otherwise unremarkable. She had a medical history of obesity, with a BMI of 39 kg/m2. She reported a family history of ovarian cancer in a first-degree relative at a young age. Pelvic magnetic resonance imaging (MRI) (Fig. 1) demonstrated a normal-sized uterus and ovaries, with no structural pathology identified. The patient requested definitive surgical management, citing persistent symptoms, intolerance of hormonal therapy and concern regarding her family history of ovarian cancer. She did not wish to have children. She was counselled extensively regarding surgical risks, fertility implications and the long-term consequences of oophorectomy, including premature menopause and the requirement for hormone replacement therapy. Given her young age and the absence of confirmed genetic risk, a shared decision was reached to refer for genetic counselling. The patient proceeded with a total laparoscopic hysterectomy and bilateral salpingectomy with conservation of the ovaries. T2-weighted pelvic MRI demonstrating a small uterus (yellow star). (A) Sagital view. (B) Coronal view. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) Investigations Following surgery, macroscopic histopathological examination revealed a diffusely haemorrhagic myometrium with innumerable small cystic spaces, described as sponge-like (Fig. 2). Microscopically, the endometrium was inactive with several small benign endometrial polyps and no evidence of hyperplasia or malignancy. Throughout the myometrium of the uterine corpus and cervix, there were innumerable dilated thick- and thin-walled blood vessels lined by a single layer of bland endothelial cells (Fig. 3). These vascular channels were diffuse and not mass-forming. The cervical mucosa showed ectropion and benign endocervical polyps with chronic cervicitis, without evidence of HPV–related changes or neoplasia. Both fallopian tubes in their entirety were submitted for histological examination, with no evidence of serous tubal intraepithelial carcinoma or invasive malignancy. Macroscopic appearances. Sliced posterior half of the uterine corpus and cervix to demonstrate diffusely haemorrhagic and sponge-like myometrium. Microscopic appearances. (A) x25 magnification, full-thickness cervix and uterine body, demonstrating a diffuse proliferation of ectatic, variably sized thick- and thin-walled blood vessels. (B) x100 magnification, myometrium of uterine body, demonstrating thick- and thin-walled blood vessels. (C) x400 magnification, myometrium of uterine body, to show vascular channels lined by a single layer of bland endothelial cells. The histological features were consistent with angiomatosis of the uterine corpus and cervix. Ancilliary testing was not required. Histologically, the principal differential was of a vascular or smooth muscle neoplasm. Whilst a cavernous or capillary haemangioma could be considered, these are generally well circumscribed with a lobular architecture, unlike the diffuse distribution of the vessels in this case. Uterine angioleiomyoma has rarely been reported; again, these form a well-defined lesion [1]. Intramuscular angioma has a more infiltrative edge but is still mass-forming and arises in skeletal (or exceptionally cardiac) muscle [2]. Similarly, a well-differentiated angiosarcoma would show mass formation, and at least some degree of endothelial cell atypia. Outcome and Follow-Up The patient's postoperative recovery was uncomplicated and her symptoms resolved. She was diagnosed with invasive triple-negative carcinoma of the left breast within the same year of the surgery. On genetic testing a hereditary cause was not found for her breast cancer. Discussion Angiomatosis is a rare, benign vascular malformation most commonly affecting the lower extremities [3]. It is characterised by a diffuse, haphazard proliferation of thick- and thin-walled blood vessels, often described as interspersed in adipose and fibrous tissue. Although angiomatosis may appear clinically similar to capillary haemangiomas, it is distinct due to its diffuse infiltration and higher rate of recurrence [4]. It also differs from congenital vascular malformations such as arteriovenous malformation (AVMs), which are abnormal connections between arteries and veins, and from acquired forms of angiomatosis, such as bacillary angiomatosis, which occur predominantly in immunosuppressed patients, generally in skin or mucosal sites [5], [6]. It should be noted that much of the literature describes cases defined as angiomatosis of soft tissue (AST). This tends to have a predilection for the hands and feet, with histological features of a generalised mesenchymal hyperplasia in which there are adipose, lymphatic and neurological components alongside the characteristic vascular proliferation [5]. Elsewhere, angiomatosis is described as a diffuse vascular lesion involving multiple tissue planes [4]. Neither of the above definitions is entirely appropriate for the present case, in which a purely vascular proliferation involved one tissue plane only (the myometrium). However, there appears to be clinical, histological and molecular overlap between these entities, and further work is required to establish how best to define cases of seemingly isolated angiomatosis of one site. A retrospective series of 51 cases of angiomatosis found it typically presents within the first two decades of life with a slightly higher prevalence in females [7]. Angiomatosis has been associated with rare vascular genetic disorders, including Klippel-Trenaunay-Weber syndrome, Von-Hippel-Lindau, Sneddon's syndrome, PTEN hamartoma tumour syndromes and Gorham disease [3], [4], [8]. Two other reported cases of uterine angiomatosis occurred in patients with Klippel-Trenaunay-Weber syndrome, further supporting this association [9], [10]. Although its aetiology remains unknown, somatic mutations in PIK3CA have been shown to be associated with angiomatosis of soft tissue (AST), with one study identifying mutations in nearly half of patients [8]. Klippel-Trenaunay- Weber syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS), suggesting that angiomatosis and Klippel-Trenaunay may share a common molecular pathogenesis [11], [12], [13]. PTEN hamartoma tumour syndromes have also been implicated in angiomatosis; PTEN and PIK3CA are involved in the same signal transduction pathway [5], [8]. Despite being diagnosed with uterine angiomatosis, the present patient did not have the associated features of any of the above syndromes. The clinical presentation of angiomatosis varies according to the location of the lesion, with cases of uterine angiomatosis describing dysmenorrhoea and menorrhagia as the primary symptoms [14], [15]. Similarly, the patient described in this report presented with pelvic pain and menorrhagia. Although pathologically distinct, a review of cervical haemangiomas also identified abnormal uterine bleeding to be the primary presenting complaint [16]. These findings suggest that vascular anomalies such as angiomatosis and angiomas should be considered in the differential diagnosis of unresolved uterine bleeding. Most cases of angiomatosis of the uterus are diagnosed on histopathology. This highlights the diagnostic challenge, as conventional investigations such as hysteroscopy and ultrasonography appear to be inadequate for a diagnosis [14], [15], [17]. However, a literature review (Table 1) identified two cases of uterine angiomatosis and cervix which were diagnosed through ultrasonography. The first, identified by Verheijen et al. (1989), described a patient with a history of Klippel-Trenaunay- Weber syndrome with arterio-venous anastomosis in the right popliteal artery and haemangiomas of the skin. During the second trimester, angiomatosis was identified through ultrasonography localised to the lower right and left side of the uterus, with doppler imaging demonstrating variable flow pattern within the uterine wall [9]. In the second case, the patient also had Klippel-Trenaunay-Weber syndrome as well as the classic triad of port-wine stains, vascular malformations and abnormal growth of bones and soft tissue. Similarly, ultrasonography in the first trimester identified vascular thickening of the uterine wall, extending to the cervix and bladder [10]. Although both cases were described as angiomatosis, the absence of histopathological analysis diminishes the clarity of whether these two cases were true angiomatosis as described in more recent reports. Furthermore, both cases describe a more localised proliferation suggesting syndrome-associated angiomatosis may be histologically distinct from angiomatosis in the absence of a syndrome. Table 1Summary of reported cases of angiomatosis of the uterus and cervix.Author, DateAgeAffected areasCo-morbiditiesDiagnosisSymptomsVerheijen et al., 1989 [9].28Lower right and left side of uterus localised to lower uterine areaKlippel-Trenaunay-Weber syndrome, pregnantUltrasonography and post-hysterectomyN/ARichards et al., 1997 [10].31Right and left lateral aspects, fundus, anterior lower uterine segment- extends under the bladder, anterior cervix and external cervical OsKlippel-Trenaunay-Weber, pregnantUltrasonographyN/APontré et al., 2017 [14].27Stroma of cervix, uterine myometrium and fallopian tube muscularisN/APost-hysterectomy histopathologicalMenorrhagiaPrakash, 2021 [15].34Uterine wall and cervical stromaN/APost-hysterectomy histopathologicalAbnormal uterine bleeding and dysmenorrhoeaAl-Ibraheem, 2023 [17].45Uterine myometrium, adnexa and cervixUterine leiomyomaPost-hysterectomy histopathologicalAbdominal distension and Abdominal pain Summary of reported cases of angiomatosis of the uterus and cervix. Al-Ibraheem et al. (2023) described the usage of fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in a 45-year-old patient with uterine leiomyoma and co-existing angiomatosis of the myometrium, cervix and adnexa. Increased FDG uptake was observed at the site of the uterine mass, exceeding that typically seen in uterine leiomyomas, indicative of the combined metabolic activity of a second pathology [17]. Similar findings have been reported in a study analysing skeletal hemangiomatosis, which showed increased FDG uptake in a patient presenting with back pain for suspected metastatic carcinoma [18]. However, another study examining systemic cystic angiomatosis identified non-specific FDG uptake in the affected lesions, suggesting that the diagnostic use of PET/CT scans remain inconclusive for angiomatosis and similar vascular malformations [19]. In this literature review, over half of reported cases of uterine angiomatosis were managed surgically with hysterectomy due to intractable uterine bleeding and/or pelvic pain. Typical measures such as the levonorgestrel-releasing intrauterine device (LNG-IUD), the first-line option for managing menorrhagia, reported by Pontré et al. (2017), failed to sufficiently manage symptoms resulting in surgical management [14], [20]. Due to the rarity of this condition, understanding of its progression is largely unknown. Hysterectomy appears to be curative in reported cases but follow-up with the patient to manage symptoms is advised [14], [15]. Whilst the development of malignancies has been documented in association with angiomatoses harbouring certain germline or somatic mutations, malignant progression of uterine angiomatosis has not been reported [11]. Contributors Zubaydah Abdi contributed to conception of the case report, drafting the manuscript and undertaking the literature review. Sadia Zare contributed to conception of the case report, acquiring and interpreting the data and drafting the manuscript. Ruth Grundy contributed to conception of the case report, acquiring and interpreting the data (histopathology) and drafting the manuscript. Alexander Polson contributed to conception of the case report and revising the article for important intellectual content. Salwa Idle contributed to patient care, conception of the case report and revising the article for important intellectual content. All authors approve the final submitted manuscript. Patient consent Written informed consent was obtained from the patient for the publication of the case report and accompanying images. Provenance and peer review This article was not commissioned and was peer reviewed. Ethics declaration Written informed consent to take part in the study and to publish the article has been obtained from all participants or their legal representatives. The privacy rights of participants have been observed. This study included organ or tissue donors. This study includes human biological material and consent was obtained by donors, or their next of kin or legal representatives, for use in this study and for publication of the article. The samples used in this research were not sourced from executed prisoners or prisoners of conscience. This study was performed in compliance with relevant laws, regulatory frameworks and guidelines where the research took place. Ethics committee approval was not required under relevant laws and institutional guidelines. Written informed patient consent was obtained. This research follows the CARE guidelines and the CARE checklist. Funding No funding from an external source supported the publication of this case report. Declaration of competing interest The authors declare that they have no competing interest regarding the publication of this case report. References